HIV Medications for HIV Prevention: News & Research
- Asking About Sexual Behavior and PrEP in Toronto (March 2012)
To read PDF, click here.
In Treatment Update, from Canadian AIDS Treatment Information Exchange
On TheBodyPRO.com
- Getting to Know PEP and PreP (March 2012)
To read PDF, click here.
In Treatment Update, from Canadian AIDS Treatment Information Exchange
- A Year of Highs and Lows in PrEP: Breaking Down the Data and Decisions From 2011 (March 2012)
To read PDF, click here.
In GMHC Treatment Issues, from Gay Men's Health Crisis
On TheBodyPRO.com
- Risky Business and PrEP Interest in Chicago STI Clinic (January/February 2012)
To read PDF, click here.
In Positively Aware, from Test Positive Aware Network
- U.S. FDA Grants Priority Review for Truvada for Reducing the Risk of Acquiring HIV Infection (February 13, 2012)
From Gilead Sciences, Inc.
- Concerns Over Using ARV Therapy as Prevention Strategy (January 9, 2012)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- UNC HIV Researcher Cohen Discusses His Work, HPTN 052 (January 5, 2012)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- British Columbia's "Treatment-as-Prevention Strategy" Helping to Reduce HIV/AIDS Cases, Deaths (January 5, 2012)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- Treatment as Prevention Is One of the Top Stories of 2011 (December 23, 2011)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- HIV Study Named 2011 Breakthrough of the Year by Science (December 22, 2011)
NIH-funded treatment-as-prevention study heralded as a major advance.
From U.S. National Institute of Allergy and Infectious Diseases
- Gilead Seeks First-Ever Approval for Drug to Prevent HIV (December 16, 2011)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Gilead Submits Application to FDA Asking for PrEP Approval for Truvada (December 16, 2011)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- Does PrEP Stop HIV in Its Tracks? (November/December 2011)
Highlight from 6th IAS Conference on Pathogenesis, Treatment and Prevention.
To read PDF, click here.
In Positively Aware, from Test Positive Aware Network
 Top 10 HIV/AIDS-Related Clinical Developments of 2011 (December 1, 2011)
David Alain Wohl, M.D., on HIV treatment as prevention; the dawning of pre-exposure prophylaxis (PrEP), but with women absent; the concept of "viremia copy-years"; the impact of race and gender on HIV treatment outcomes; setbacks for two treatment approaches involving Isentress; new hepatitis C therapies; a new once-daily HIV pill; the rising rates of HIV among black MSM; and what comes after "test and treat."
From TheBody.com
- Pivotal HIV Prevention Trial for Women in Africa Finds That Use of Tenofovir Gel Does Not Prevent HIV: What Does This Mean for HIV Prevention for Women? (November 28, 2011)
Global Campaign for Microbicides statement on the VOICE DSMB decision to discontinue use of tenofovir gel.
From Global Campaign for Microbicides
- NIH Discontinues Tenofovir Vaginal Gel in "VOICE" HIV Prevention Study (November 25, 2011)
Product safe but no more effective than placebo.
From U.S. National Institutes of Health
- VOICE Trial Changes Are Disappointing, Says AVAC; Calls for Continued Research to Find New Prevention Options for Women (November 25, 2011)
To read PDF, click here.
From AIDS Vaccine Advocacy Coalition
- Experts Discuss Treatment as Prevention at USAID-, World Bank-Sponsored Debate (November 14, 2011)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- Massachusetts Group, Others Push for HIV Prevention Pill (October 25, 2011)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
 The Death of the Pariah: A Blog Entry by Jeannie Wraight (October 12, 2011)
"Please, don't let anyone, including yourself, make you feel diseased or contagious or like a threat ever again. HIV science and medicine have come a long way. The stigma we have faced was always wrong and now even more so. Let's bury the pariah."
From TheBody.com
- 96% Campaign Asks Obama to "Pay Attention to Science" and Scale Up Global Access to ARVs (October 10, 2011)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
|
Advertisement
|
Email
Glossary
